Luminoah, Inc. — SEC Form D Filing

Luminoah, Inc. filed an SEC Form D on November 6, 2026, reporting $25.41M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
November 6, 2026
Amount reported
$25.41M
Round stage
Series A
Industry
Medical Devices
Website
https://luminoah.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Individuals who rely on enteral nutrition (tube feeding) typically face restrictive and cumbersome equipment, often leaving them tethered to IV poles or forced to carry bulky backpacks.

Solution

Luminoah developed Luminoah Flow, a compact and lightweight enteral feeding system featuring a wearable pump, an intuitive touchscreen, and a companion mobile app for real-time tracking and delivery management.

Why now

Advances in hardware miniaturization, battery density, and mobile connectivity enable traditional institutional medical devices to shift into portable, patient-friendly home-use form factors.

Verdict

Luminoah secured $25M because investors saw an immediate consumerization wedge in a stagnant, highly concentrated reimbursement category, betting that miniaturized hardware and connected compliance data could wrest prescription share from entrenched hospital-grade incumbents. This cleared because it packaged proven enteral nutrition reimbursement codes into an undeniably superior ambulatory patient experience, not because the underlying delivery mechanism possessed deep technological defensibility. Upside is structurally constrained by durable medical equipment distributor margins and the friction of unseating legacy players from institutional discharge formularies.

Source: SEC EDGAR Form D filing